clinicalStudies
She
youngPatients
index
screeningBehavior
excision
FilipinoWomen
scanTime
novelTargetedTherapeuticOptions
novelTechnique
BACKGROUND
CXCR4
results
hormonalContraceptionUse
18F-FDGPET/CTImages
intake
strongIndependentPrognosticFactor
novelTherapeuticOptions
patients
selectedCases
betterOutcome
tumorDetectability
components
imagesneed
we
longScanTime
cohortStudy
agreement
contrastAgents
third-degree
smallMoleculeInhibitors
appropriateness
theResulting
powerfulTechnique
breastExamination
CXCR4-directedPETImaging
Metastases
LungCancer
complexDisease
definitiveDiagnosis
Anthracyclines
Aims
amount
theirEmergingRole
performance
analysis
Osteopontin-750Accumulation
CXCR4-targetedPETImaging
allotting
cancer
unenhancedMRITechniques
osteopontin-basedProbe
p
SeromaFormation
article
therapeuticOptions
BetterUnderstanding
cTnLevels
relationship
moreSpecificApplications
homologousRecombinationPathway
address
signature
HealthcarePolicyMakers
dose-dependentReduction
CoxProportionalHazardRegressionModels
cancerRiskPerception
largerProspectiveStudies
Patients
initialResults
rareClinicalEntity
doses
search
screeningMammography
fourPatients
OurFindings
breastCancerDiagnosis
probe
Information
lungCancer
imagingProtocol
symptomControl
theirAbility
tumor-to-backgroundRatios
radicalSurgicalApproaches
contrast-enhancedScreeningTools
differentialDiagnosis
recentDanishCohortStudy
imagingTechnique
MedianAmount
24ApplicableCases
breastImagingModality
TenStudies
ManyFeatures
They
lowCTnLevels
cardiotoxicityDiagnosis
evaluation
targetedTherapeuticOptions
images
importantCornerstone
summaryHazardRatios
comprehensiveSearch
highIndex
significantAdvances
surgicalExcision
women
targetedOptions
she
novelTargetedOptions
Ulceration
alternativeScreeningTools
they
tumour
We
increase
Forty-threeCases
BRD4Regulation
disease
IORT
biomarker
SimilarTowaveletFilter
membraneTypeMR
understanding
581Patients
discovery
options
recombinationPathway
Mammography
Radiotherapy
locoregionalRadiotherapy
role
elderlyPatient
treatment
contraceptionUse
postmenopausalPatient
multiresolutionResult
acromegaly
RESULTS
radiotherapy
membraneTypeMannoseReceptor
identification
primaryTumour
novelPowerfulTechnique
40
collectedSignatures
novelOptions
cornerstone
ObservationalStudies
troponins
Extra-TerminalBETProteins
bleeding
ColorectalCancer
mutations
MRI
seromaProduction
technique
differentStudies
FemalePatients
strongAssociation
five
largerStudies
case
highCosts
lesion
costs
12SampledWomen
FurtherDevelopment
studies
neuroma
95%ConfidenceIntervals
I2
it
BreastCancer
ConservativeTreatment
HerPresentation
observedVariation
People
directRelationship
prospectiveStudies
screeningTools
Comparison
anti-HER2Therapy
Efforts
CardiacTroponins
BreastCancer
MedianFollow-up
herDisease
Diagnosis
association
result
%
466%
towaveletFilter
alternativeContrast-enhancedScreeningTools
%ConfidenceIntervals
theirInhibition
MedianAge
X-rayMammography
study
time
mammographicImages
diagnosticPerformance
numerousGene-expression-basedSignatures
research
MRITechniques
aim
the
mostPatients
breastCancer
infraredFluorescentImaging
familialCancerClustering
onePatient
most
reproducibilityStudies
prognosticSignatures
24Cases
subcutaneousBreastTumor
Anti-HER2Therapies
breastCancerEffects
decreases
glycosylationSites
necessity
ImprovedDetection
currentDevelopments
DiagnosticEvaluation
strongContrast
FluorescenceImagingExVivo
markedReduction
OurLiteratureReview
increasedRisk
respondents
patient
BETProteins
standardizedImagingProtocol
risk
heterogeneousCancer
DanishCohortStudy
barcodeMode
clinicians
TraumaticNeuroma
TraumaticBreastNeuromas
follow-up
signatures
gene-expression-basedPrognosticSignatures
numerousGene-expression-basedPrognosticSignatures
MSOTImaging
deterioration
longTime
numerousPrognosticSignatures
subtype-specificSignature
breastNeuromas
higher
ThirteenPatients
features
theirCardiotoxicities
MRIProtocols
traumaticNeuroma
imagingFeatures
development
diagnosis
update
numerousSignatures
availableContrastAgents
gene-expression-basedSignatures
improvedBreastCancerOS
cases
1
detection
CoxHazardRegressionModels
repair
signalIntensity
use
SelectiveBinding
subjectiveRisk
binding
Bromodomain
12-15%
involved
retrospectiveAnalysis
ConventionalX-rayMammography
BRD4PharmacologicalInhibition
higherSUVmax
PETImaging
Breast
exhibiting
adjustment
1062Patients
FurtherResearch
breast
AION
detectionofBreastCancer
recentCohortStudy
commonCancer
BRCAnessPhenotype
routineClinicalBiomarker
Transcripts
higherResolution
age
moleculeInhibitors
PatientDemographics
prolongedRecovery
experiences
segmentationAlgorithm
metastaticDisease
BRD4Inhibition
response
pharmacologicalInduction
cTn
SixGlycosylationSites
clinicalBreastExamination
TNBC